Chronic Alcohol Exposure Can Affect Brain Protein Expression
Researchers at the University at Buffalo studying the effects of alcohol on the brain, using zebrafish as a model, have identified several novel central nervous system proteins that are affected by chronic alcohol exposure. view more (2006-08-30)
Worm's hunger response provides clue to eating disorders
In research that may have implications for studying eating disorders in humans, a worm the size of a pinhead is helping researchers at UT Southwestern Medical Center unravel the mechanisms of hunger. view more (2006-04-05)
Ancient DNA helps UF researchers unearth potential hemophilia therapy
A cut can be life-threatening for people with hemophilia, whose bodies don't produce enough of a protein that prevents prolonged bleeding. view more (2006-02-28)
Antipsychotic drug may block addiction, UIC researchers find
Researchers at the University of Illinois at Chicago have discovered that a long-approved oral antipsychotic drug can stop the addictive properties of opioid painkillers in mice. view more (2006-02-09)
UNC scientists discover 'gatekeeper' protein in blood clotting
New research from the University of North Carolina at Chapel Hill School of Medicine has identified a protein that may control blood clotting by keeping blood platelets from sticking together. view more (2006-01-30)
UCSD team unmasks family of immune system invaders
Like a family of petty criminals gone wrong, researchers at the University of California, San Diego (UCSD) were surprised to find that bacterial pathogens found in a number of troublesome diseases are actually related. view more (2006-01-13)
Tumor cells that border normal tissue are told to leave
The thin, single-cell boundary where a tumor meets normal tissue is the most dangerous part of a cancer according to a new study by scientists at Washington University School of Medicine in St. Louis. view more (2006-01-11)
Scientists pool information to boost understanding of drug action
As a result of the Human Genome Project, scientists now know the human DNA codes for about 20,000-25,000 genes, each of which could be a target for the development of new medicines. However, most scientists believe that only about 10% of these genes are likely targets for the drugs of the future. view more (2005-12-01)
The dangerous legacy of lead
Although lead is a well-known human health hazard, researchers at the University of Rochester Medical Center have discovered a new aspect of how it may work in mice to harm the function of T-cells. view more (2005-11-16)
Carbon nanoparticles stimulate blood clotting, researchers report
Carbon nanoparticles - both those unleashed in the air by engine exhaust and the engineered structures thought to have great potential in medical applications - promote blood-clotting. view more (2005-10-24)
Feedback loop found that could forestall liver disease
Researchers at UT Southwestern Medical Center have discovered that the small intestine communicates with the liver to control the production of bile acids-a finding that has great medical implications in treating people at risk for certain types of liver disease. view more (2005-10-12)
Egg's Energy Stores Key to Preserving Fertility
An immature egg's internal nutrient supply is critical to its survival, an insight that offers a new route to understanding and treating infertility due to egg death. view more (2005-10-07)
Research offers new approach to developing treatments for cocaine and amphetamine addiction
The study shows that highly addictive drugs, like cocaine and amphetamine, require a neurotransmitter called CART (Cocaine- and Amphetamine-Regulated Transcript) peptides to produce their maximal effects. view more (2005-09-29)
Dangerous interaction between the antibiotic ciprofloxacin and the muscle relaxant tizanidine
Researchers from Finland have found that the antibiotic ciprofloxacin (brand names Ciproxin, Ciprofloxacin etc.) greatly increases the concentrations of tizanidine (Sirdalud, Zanaflex) in blood. Concomitant use of ciprofloxacin and tizanidine results in severe and prolonged decrease in blood pressure and greatly enhances central nervous system... view more... (2004-12-15)
University to train modern Sherlock Holmes
A North-East university will soon be training detectives of the future by using innovative methods popularised through TV shows like CSI Miami and Waking the Dead. view more (2004-12-13)
New University of Bath arrival could help banish painful injections
One of the world's leading experts on a new technique that could make painful injections a thing of the past, arrives at the University of Bath as the new Professor of Pharmaceutical Sciences this month. Professor Richard Guy is joining the Department of Pharmacy and Pharmacology after eight years at the University of Geneva in Switzerland. He is... view more... (2004-08-16)
New Principal & Dean at the Royal Veterinary College
The new Principal and Dean of the Royal Veterinary College, Professor Quintin McKellar took up post on 1st August 2004. Prior to this appointment, Professor McKellar was the director of the Moredun Research Institute after holding the post of Professor of Veterinary Pharmacology at the University of Glasgow. His interests are in animal... view more... (2004-08-04)
Labs on a chip
The American bio-technology company, WaferGen, is planning to produce three micro laboratories on three different sensor chips, which were developed in Delft. To this end the company will acquire licences to for the patented design. The contracts will be signed by representatives of WaferGen and by Ir. G.J. van Luijk (chairman of the TU Delft... view more... (2004-06-03)
Joop Hermens awarded SETAC Europe Environmental Education Award
Dr. Joop Hermens was awarded the 2004 Society of Environmental Toxicology and Chemistry (SETAC) Europe Environmental Education Award, sponsored by Dr. U. Noack Laboratorien. Though the award was intended to honor Hermens, he saw it as an acknowledgement of the effort from the environmental toxicology and chemistry research group at the Institute... view more... (2004-05-17)
Dangerous Interaction Between The Antidepressant Fluvoxamine (Fevarin, Faverin, Luvox) And The Muscle Relaxant Tizanidine (Sirdalud, Zanaflex)
Researchers from Finland have found that the antidepressant drug fluvoxamine (brand names Fevarin, Faverin, Luvox etc.) drastically increases the concentrations of tizanidine (Sirdalud, Zanaflex) in blood. Concomitant use of fluvoxamine and tizanidine results in severe and prolonged decrease in blood pressure and greatly enhanced central nervous... view more... (2004-04-06)
|
|
